TriangleNCT01696994 · OUTCOME
Ovarian Cancer Death Rates (Including Primary Peritoneal and Fallopian Tube Cancers)
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- Deaths per 10,000 PY
- Interval / dispersion
- Not reported
- Time frame
- Events through 13 years of follow-up or through December 31, 2009; median follow-up 11.9 years.
What was measured
Ovarian cancer deaths confirmed in participants by a death review committee if available, otherwise by death certificate. Rate is the number of deaths divided by person years of follow-up in the study.
Analysis population: Female participants, excluding females without ovaries at baseline, were analyzed. An intention-to-treat analysis was performed.
Groups in this outcome
Control
Participants receive standard medical care.
Ovarian Screening
Participants undergo blood sample collection for CA125 analysis at baseline annually for 5 years. Participants also undergo an OVR (discontinued in December 1998) and TVU at baseline and annually for 3 years.
| Group | Source count |
|---|---|
| Control | 34304 |
| Ovarian Screening | 34253 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Control | 2.6 | Not reported | Not reported | Not reported | Not reported |
| Ovarian Screening | 3.1 | Not reported | Not reported | Not reported | Not reported |
Source statistical analyses
- ci Lower Limit
- .91
- ci Num Sides
- TWO_SIDED
- ci Pct Value
- 95
- ci Upper Limit
- 1.54
- group Ids
- OG000
- OG001
- non Inferiority Type
- SUPERIORITY_OR_OTHER_LEGACY
- p Value Comment
- Two-sided. Not adjusted for multiple comparisons. A-priori threshold for significance 0.05.
- param Type
- Hazard Ratio (HR)
- param Value
- 1.18
- statistical Method
- Poisson regression
Complete source fields
- analyses
- ci Lower Limit
- .91
- ci Num Sides
- TWO_SIDED
- ci Pct Value
- 95
- ci Upper Limit
- 1.54
- group Ids
- OG000
- OG001
- non Inferiority Type
- SUPERIORITY_OR_OTHER_LEGACY
- p Value Comment
- Two-sided. Not adjusted for multiple comparisons. A-priori threshold for significance 0.05.
- param Type
- Hazard Ratio (HR)
- param Value
- 1.18
- statistical Method
- Poisson regression
- classes
- categories
- measurements
- group Id
- OG000
- value
- 2.6
- group Id
- OG001
- value
- 3.1
- denoms
- counts
- group Id
- OG000
- value
- 34304
- group Id
- OG001
- value
- 34253
- units
- Participants
- description
- Ovarian cancer deaths confirmed in participants by a death review committee if available, otherwise by death certificate. Rate is the number of deaths divided by person years of follow-up in the study.
- groups
- description
- Participants receive standard medical care.
- id
- OG000
- title
- Control
- description
- Participants undergo blood sample collection for CA125 analysis at baseline annually for 5 years. Participants also undergo an OVR (discontinued in December 1998) and TVU at baseline and annually for 3 years.
- id
- OG001
- title
- Ovarian Screening
- param Type
- NUMBER
- population Description
- Female participants, excluding females without ovaries at baseline, were analyzed. An intention-to-treat analysis was performed.
- reporting Status
- POSTED
- time Frame
- Events through 13 years of follow-up or through December 31, 2009; median follow-up 11.9 years.
- title
- Ovarian Cancer Death Rates (Including Primary Peritoneal and Fallopian Tube Cancers)
- type
- PRIMARY
- unit Of Measure
- Deaths per 10,000 PY
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice